These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 20547213)
1. Spinal upregulation of glutamate transporter GLT-1 by ceftriaxone: therapeutic efficacy in a range of experimental nervous system disorders. Ramos KM; Lewis MT; Morgan KN; Crysdale NY; Kroll JL; Taylor FR; Harrison JA; Sloane EM; Maier SF; Watkins LR Neuroscience; 2010 Sep; 169(4):1888-900. PubMed ID: 20547213 [TBL] [Abstract][Full Text] [Related]
2. Upregulation of GLT-1 by treatment with ceftriaxone alleviates radicular pain by reducing spinal astrocyte activation and neuronal hyperexcitability. Nicholson KJ; Gilliland TM; Winkelstein BA J Neurosci Res; 2014 Jan; 92(1):116-29. PubMed ID: 24123246 [TBL] [Abstract][Full Text] [Related]
3. An anti-nociceptive role for ceftriaxone in chronic neuropathic pain in rats. Hu Y; Li W; Lu L; Cai J; Xian X; Zhang M; Li Q; Li L Pain; 2010 Feb; 148(2):284-301. PubMed ID: 20022427 [TBL] [Abstract][Full Text] [Related]
4. The β-lactam clavulanic acid mediates glutamate transport-sensitive pain relief in a rat model of neuropathic pain. Kristensen PJ; Gegelashvili G; Munro G; Heegaard AM; Bjerrum OJ Eur J Pain; 2018 Feb; 22(2):282-294. PubMed ID: 28984398 [TBL] [Abstract][Full Text] [Related]
5. The beta-lactam antibiotic, ceftriaxone, inhibits the development of opioid-induced hyperalgesia in mice. Chen Z; He Y; Wang ZJ Neurosci Lett; 2012 Feb; 509(2):69-71. PubMed ID: 22212402 [TBL] [Abstract][Full Text] [Related]
6. Valproate prevents dysregulation of spinal glutamate and reduces the development of hypersensitivity in rats after peripheral nerve injury. Yoshizumi M; Eisenach JC; Hayashida K J Pain; 2013 Nov; 14(11):1485-91. PubMed ID: 24021575 [TBL] [Abstract][Full Text] [Related]
7. Gene transfer of GLT-1, a glial glutamate transporter, into the spinal cord by recombinant adenovirus attenuates inflammatory and neuropathic pain in rats. Maeda S; Kawamoto A; Yatani Y; Shirakawa H; Nakagawa T; Kaneko S Mol Pain; 2008 Dec; 4():65. PubMed ID: 19108711 [TBL] [Abstract][Full Text] [Related]
9. Altered expression and uptake activity of spinal glutamate transporters after nerve injury contribute to the pathogenesis of neuropathic pain in rats. Sung B; Lim G; Mao J J Neurosci; 2003 Apr; 23(7):2899-910. PubMed ID: 12684477 [TBL] [Abstract][Full Text] [Related]
10. Ceftriaxone-mediated upregulation of the glutamate transporter GLT-1 contrasts neurotoxicity evoked by kainate in rat organotypic spinal cord cultures. Bajrektarevic D; Nistri A Neurotoxicology; 2017 May; 60():34-41. PubMed ID: 28257918 [TBL] [Abstract][Full Text] [Related]
11. Glycogen synthase kinase 3 beta regulates glial glutamate transporter protein expression in the spinal dorsal horn in rats with neuropathic pain. Weng HR; Gao M; Maixner DW Exp Neurol; 2014 Feb; 252():18-27. PubMed ID: 24275526 [TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor-mediated downregulation of spinal astrocytic connexin43 leads to increased glutamatergic neurotransmission and neuropathic pain in mice. Morioka N; Zhang FF; Nakamura Y; Kitamura T; Hisaoka-Nakashima K; Nakata Y Brain Behav Immun; 2015 Oct; 49():293-310. PubMed ID: 26116449 [TBL] [Abstract][Full Text] [Related]
13. [Effect of spinal glutamate transporter 1 on chronic constriction injury of sciatic nerve and morphine tolerance of rats]. Yan H; Li CM; Li YL; Gong ZH Yao Xue Xue Bao; 2009 Jun; 44(6):581-5. PubMed ID: 19806886 [TBL] [Abstract][Full Text] [Related]
14. Spinal astrocyte gap junction and glutamate transporter expression contributes to a rat model of bortezomib-induced peripheral neuropathy. Robinson CR; Dougherty PM Neuroscience; 2015 Jan; 285():1-10. PubMed ID: 25446343 [TBL] [Abstract][Full Text] [Related]
16. Beta-lactam antibiotic reduces morphine analgesic tolerance in rats through GLT-1 transporter activation. Rawls SM; Zielinski M; Patel H; Sacavage S; Baron DA; Patel D Drug Alcohol Depend; 2010 Mar; 107(2-3):261-3. PubMed ID: 20004063 [TBL] [Abstract][Full Text] [Related]
17. Ceftriaxone ameliorates tau pathology and cognitive decline via restoration of glial glutamate transporter in a mouse model of Alzheimer's disease. Zumkehr J; Rodriguez-Ortiz CJ; Cheng D; Kieu Z; Wai T; Hawkins C; Kilian J; Lim SL; Medeiros R; Kitazawa M Neurobiol Aging; 2015 Jul; 36(7):2260-2271. PubMed ID: 25964214 [TBL] [Abstract][Full Text] [Related]
18. Ceftriaxone attenuates ethanol drinking and restores extracellular glutamate concentration through normalization of GLT-1 in nucleus accumbens of male alcohol-preferring rats. Das SC; Yamamoto BK; Hristov AM; Sari Y Neuropharmacology; 2015 Oct; 97():67-74. PubMed ID: 26002627 [TBL] [Abstract][Full Text] [Related]
19. Region-specific deletions of the glutamate transporter GLT1 differentially affect nerve injury-induced neuropathic pain in mice. Zhao Z; Hiraoka Y; Ogawa H; Tanaka K Glia; 2018 Sep; 66(9):1988-1998. PubMed ID: 29722912 [TBL] [Abstract][Full Text] [Related]
20. Ceftriaxone treatment after traumatic brain injury restores expression of the glutamate transporter, GLT-1, reduces regional gliosis, and reduces post-traumatic seizures in the rat. Goodrich GS; Kabakov AY; Hameed MQ; Dhamne SC; Rosenberg PA; Rotenberg A J Neurotrauma; 2013 Aug; 30(16):1434-41. PubMed ID: 23510201 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]